BOEHRINGER INGELHEIM INTERNATIONAL GMBH;ZEALAND PHARMA A/S
发明人:
RIBER, DITTE,TOLBORG, JAKOB LIND,HAMPRECHT, DIETER WOLFGANG
申请号：
CA2927458
公开号：
CA2927458A1
申请日:
2014.10.17
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
